Company Profile

Casterbridge Pharmaceuticals Inc
Profile last edited on: 4/6/2018            CAGE: 7K9W1

New anti-infectives for treating human disease
Year Founded
1st Awd Year
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

107 Pines Street
Woburn, MA 01801
   (781) 606-2720
Multiple Locations:   
Congressional District:   05
County:   Middlesex

Public Profile

Based in Massachusetts but with lab faciliites also in Missouri, Casterbridge Pharmaceuticals Inc. is a specialty Biotech company focused on the development of small-molecule anti-infectives drugs directed at important human disease. The firm's lead program: Herpes Simplex Virus Pre-Clinical R&D Program HSV-1 persistently infects nearly 2/3 of the U.S. population. The causes recurrent cold sores, more serious disease including potentially blinding stromal keratitis that affects 450,000 people in the U.S., and rare but often fatal encephalitis. Nearly 1 in 5 Americans is infected with HSV-2, and the global burden of HSV-2 infection extends to more than half a billion persons. The cost of incident HSV infections in the year 2000 was estimated to be $1.8 billion and is predicted to rise to $2.7 billion by 2015. Furthermore, viruses resistant to current therapies have emerged among pediatric patients, those with keratitis, and immunocompromised patients. Existing alternative therapies are few, are incompletely effective, and have high toxicity. Thus, new drugs against HSV-1 and HSV-2 are greatly needed. Casterbridge Pharmaceuticals Inc. is executing a pre-Clinical R&D program to discover and develop new potent anti-HSV drug candidates for Clinical Development.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
Less than .5M
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  Bruce Lee Rogers -- Founder, President, and CEO

  Bruce Lee Rogers

  Bruce Lee Rogers

SBIR firms in the news

There are no news available.